Clinical Trials Logo

Hyperemesis Gravidarum clinical trials

View clinical trials related to Hyperemesis Gravidarum.

Filter by:
  • Recruiting  
  • Page 1

NCT ID: NCT06266819 Recruiting - Clinical trials for Hyperemesis Gravidarum

The Effect of Mint Flavored Chewing Gum on Hyperemesis Gravidarum Nausea Vomiting Severity, Coping With Stress and Anxiety Level in Pregnants With Hyperemesis Gravidarum

Start date: January 15, 2024
Phase: N/A
Study type: Interventional

In the research planned as a randomized controlled study, the experimental groups will be administered routine hyperemesis gravidarum (HG) treatment as well as chewing mint-flavored gum, while the control group will only receive routine HG treatment and no intervention will be performed. This study aims to contribute to the literature by investigating the effect of chewing mint-flavored gum on the severity of nausea and vomiting, coping with stress, and anxiety levels due to hyperemesis gravidarum in pregnant women.

NCT ID: NCT05244460 Recruiting - Clinical trials for Cannabis Hyperemesis Syndrome

Droperidol on Prevention of Cannabis Hyperemesis Syndrome

DOPE
Start date: December 2, 2021
Phase: Phase 3
Study type: Interventional

The purpose of this study is to assess the efficacy of droperidol as a treatment of cannabinoid hyperemesis syndrome.

NCT ID: NCT04283292 Recruiting - Clinical trials for Cannabinoid Hyperemesis Syndrome

Capsaicin for the Treatment of Cannabinoid Hyperemesis Syndrome

Start date: December 1, 2020
Phase: Phase 4
Study type: Interventional

This study aims to determine if capsaicin cream offers symptomatic relief to patients suffering from Cannabinoid Hyperemesis Syndrome (condition that leads to repeated and severe bouts of vomiting).

NCT ID: NCT02989337 Recruiting - Clinical trials for Hyperemesis; Gravidarum, With Dehydration

Endothelial Dysfunction in Hyperemesis Gravidarum

Start date: December 2016
Phase: N/A
Study type: Observational

The purpose of the study is to determine serum inflammatory adhesion molecules levels in hyperemesis gravidarum

NCT ID: NCT02862496 Recruiting - Clinical trials for Hyperemesis Gravidarum

Bone Health in Hyperemesis Gravidarum

Start date: June 2016
Phase: N/A
Study type: Observational [Patient Registry]

The purpose of the study is to determine whether maternal bone resorption would be seen in Hyperemesis Gravidarum and could be detected in early period using serum vitamin D levels, serum calcium (Ca) levels, serum parathormone (PTH) levels and urine N- telopeptide levels in the patients with Hyperemesis Gravidarum.

NCT ID: NCT02619188 Recruiting - Pregnancy Clinical Trials

Nutritional Markers in Normal and Hyperemesis Pregnancies

PUQE-M
Start date: September 2015
Phase: N/A
Study type: Observational

This study evaluate the rate of nausea and nutritional status in patients with hyperemesis gravidarum (severe nausea and vomiting in pregnancy) and healthy pregnant women using a questionnaire (PUQE-score), self-reported food/drink intake form and blood test. The Investigators aim for developing normal range of prealbumin measurements (reference values) during first trimester of pregnancy.